These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9367293)

  • 1. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
    Arai Y; Uchida Y; Takashima S
    Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains.
    Arai Y; Mizuguchi M; Ikeda K; Takashima S
    Brain Res Dev Brain Res; 1995 Jul; 87(2):228-32. PubMed ID: 7586507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome.
    Arai Y; Iwasaki Y; Suzuki T; Ide S; Kaga M
    Brain Dev; 2019 Jan; 41(1):106-110. PubMed ID: 30086988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome.
    Mito T; Becker LE
    Exp Neurol; 1993 Apr; 120(2):170-6. PubMed ID: 8491278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive glutamate receptor 1 immunoreactivity in adult Down syndrome brains.
    Arai Y; Mizuguchi M; Takashima S
    Pediatr Neurol; 1996 Oct; 15(3):203-6. PubMed ID: 8916156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome cases.
    Takashima S; Kuruta H; Mito T; Nishizawa M; Kunishita T; Tabira T
    Brain Dev; 1990; 12(4):367-71. PubMed ID: 2146899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects.
    Dickson DW; Wertkin A; Kress Y; Ksiezak-Reding H; Yen SH
    Lab Invest; 1990 Jul; 63(1):87-99. PubMed ID: 2165197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.
    Arai Y; Suzuki A; Mizuguchi M; Takashima S
    Brain Dev; 1997 Jun; 19(4):290-4. PubMed ID: 9187481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome.
    Hirayama A; Horikoshi Y; Maeda M; Ito M; Takashima S
    Brain Dev; 2003 Apr; 25(3):180-5. PubMed ID: 12689696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to human hypoglossal nucleus which stain neurons and astrocytes in normal brains and brains from cases of Alzheimer-type dementia.
    Yates CM; Laszlo I; Fink G; Hastings I; Boyd J; James K
    Neuroscience; 1986 May; 18(1):183-91. PubMed ID: 2426629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer's disease.
    Kobayashi K; Hayashi M; Nakano H; Shimazaki M; Sugimori K; Koshino Y
    J Alzheimers Dis; 2004 Dec; 6(6):623-32; discussion 673-81. PubMed ID: 15665402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.
    Nagele RG; D'Andrea MR; Lee H; Venkataraman V; Wang HY
    Brain Res; 2003 May; 971(2):197-209. PubMed ID: 12706236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases.
    Uchida Y
    Biol Signals; 1994; 3(4):211-5. PubMed ID: 7834016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex.
    Martin LJ; Pardo CA; Cork LC; Price DL
    Am J Pathol; 1994 Dec; 145(6):1358-81. PubMed ID: 7992840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental patterns of neuronal thread protein gene expression in Down syndrome.
    de la Monte SM; Xu YY; Hutchins GM; Wands JR
    J Neurol Sci; 1996 Feb; 135(2):118-25. PubMed ID: 8867067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.